Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Hamartomas in the Young Child
Description
The presentation discusses hamartomas in young children, focusing on their classification, significance, and genetic underpinnings. Hamartomas are disorganized tissue growths arising from native cell types due to mutations. The speaker introduces different types of hamartomas, particularly epidermal nevi, and highlights the confusion in terminology, as many conditions overlap. A key point made is the role of postzygotic mutations in these developmental anomalies, which can yield varying phenotypes, making genetic diagnosis complex. The discussion includes typical conditions like tuberous sclerosis, where patients may display mosaic mutations that affect their clinical presentation. The importance of thorough examination to recognize associated risks, such as cardiac and renal complications, is emphasized. The talk also explores the significance of mutations in different pathways affecting skin growths and their potential progression to malignancies. Moreover, the speaker suggests the need for advanced genetic testing to better understand these conditions and improve patient care, noting the potential for new therapies targeting underlying genetic factors. Ultimately, the presentation encourages utilizing genetic information to enhance understanding and management of epidermal nevi and associated syndromes.
View moreConclusions
- Hamartomas are characterized as disorganized tissue growth due to activating mutations in normal cell structures.
- Epidermal nevi encompass a wide range of conditions with distinct presentations and genetic underpinnings.
- Somatic mosaicism is a key factor in many birthmarks and conditions, necessitating thorough genetic evaluation.
- Significant numbers of patients with phenotypes suggestive of tuberous sclerosis may have negative genetic tests due to undetected mosaic mutations.
- Specific mutations such as HRAS and KRAS are prevalent in certain epidermal nevi and associated syndromes.
- The presence of extensive epidermal nevi should prompt consideration of potential systemic involvement, including neurodevelopmental and skeletal concerns.
- Patients with extensive nevi may face risks for associated conditions such as hypophosphatemic rickets.
- Genetic testing may impact clinical management and monitoring in patients with epidermal nevi and associated syndromes.
- Avitan-Hersh et al. J Clin Endocrinol Metab ., 2014
- Dabora S et al. Am J Hum Genet. 2001 Jan;68(1):64-80
- Treichel AM et al. BJD 2019
- Atzmony L et al. J Cutan Pathol. 2020
- Jin H et al. Autoimmunity Reviews. 2016
- Levinsohn J et al. JAMA Derm 2015
- Riachi M et al. J Invest Dermatol. 2021
- Idriss MH et al. JAAD 2013
- Damiani L et al. Skin Appendage Disord. 2017
- Hurwitz Clinical Pediatric Dermatology 5th Edition
- Miao C et al. J Eur Acad Dermatol Venereol. 2023
- Lim Y et al. Annual Review of Genetics. 2017
- Asch S et al. Ped Dermatol 2018
- Gadea et al. J Med Genet 2020
- Siegel D et al. 2011 British Association of Dermatologists 2012
- Ovajero D et al. Osteoporos Int. 2016
- Nelson Ugwu MD et al. Pediatric Dermatology WILEY
- Happle R et al. JAAD 2010